September 1, 2010
CONTACT: Jessica Mikulski
Violence in Inner City Neighborhoods Contributes to Trouble with Asthma
Penn Study Links Community Violence with Asthma Hospitalizations and Emergency Department Visits
PHILADELPHIA – Patients with asthma who are exposed to violence in their community are at an increased risk for an asthma-related hospitalization and emergency room visits for asthma or any cause, according to new research from the Perelman School of Medicine. Exposure to community violence has been linked to more symptoms in pediatric asthma patients; however the new research adds to this finding with a longitudinal study showing a connection in an adult population and more than symptoms - actual emergency department (ED) visits and hospitalizations. The findings are reported in the September 2010 issue of The Journal of Allergy & Clinical Immunology.
“We know that asthma morbidity is high in low-income inner-city neighborhoods,” said lead author Andrea J. Apter, MD, professor of Medicine, chief, Section of Allergy and Immunology, Division of Pulmonary, Allergy, and Critical Care Medicine. “So it’s important for us to understand how poverty affects health, particularly asthma health, so we can find ways of reducing exacerbations.”
The prospective cohort study tracked 397 adults living in an inner city community with moderate to severe asthma for six months as part of a large study of asthma management. Participants were interviewed to determine sociodemographics, asthma status, asthma-specific quality of life, depressive symptoms, social support, and exposure to community violence. To define exposure to community violence, patients were asked, “in the past 6 months did you witness any violence in your neighborhood.” If they responded “yes,” they were asked to indicate all they had witnessed - “a fight in which a weapon was used, a violent argument between neighbors, a gang fight, a sexual assault or rape, a robbery or mugging” or they could write-in another description. They were then seen monthly and reports of hospitalizations and ED visits were obtained as part of data collected at these visits.
The researchers found that exposure to violence was quite common in their study group, affecting almost one-quarter of the group. Those previously exposed to violence had nearly twice the rate of subsequent hospitalizations or emergency care visits for asthma compared to asthmatics who had not experienced violence exposure. Asthma-related quality of life was also found to be lower in the violence-exposed group. Younger adults were more likely to be exposed to violence and more likely to have an ED visit in general. The researchers said it is difficult to determine exactly how exposure to violence affects health. One possibility for persons with asthma is that exposure to violence is a marker for other exposures such as physical or social conditions that contribute to the development of their disease, exacerbate their symptoms, and interfere with successful treatment and management of their condition such as outdoor pollution, inadequate housing, or limited access to pharmacies. Another possibility, and not mutually exclusive, is that the psychological stress of living in a community with concentrated disadvantage directly affects the health of persons with asthma. It is known that such stress can affect overall health.
“Because overall ED visits increased and there was a trend toward increase in overall hospitalizations, our findings suggest that exposure to violence is associated with far reaching health effects beyond the single condition of asthma,” said Apter.
The authors’ findings emphasize the importance of neighborhood factors on overall health, especially in poor inner city settings where violence is common. The findings also highlight the need for physicians to carefully evaluate each patient and consider the environment in which the patient lives in order to recommend the most effective treatments.
Additional Penn researchers involved with this study are Laura A. Garcia, MPH, Section of Allergy and Immunology, Division of Pulmonary Allergy Critical Care Medicine; Rhonda C. Boyd, PhD, Department of Child and Adolescent Psychiatry; Xingmei Wang, MS, Department of Biostatistics and Epidemiology; Daniel K. Bogen, MD, PhD, Department of Bioengineering; and Thomas Ten Have, PhD, Department of Biostatistics and Epidemiology. Funding for the study was provided in part by the National Institutes of Health.
Penn Medicine is one of the world's leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $4.3 billion enterprise.
The Perelman School of Medicine has been ranked among the top five medical schools in the United States for the past 17 years, according to U.S. News & World Report's survey of research-oriented medical schools. The School is consistently among the nation's top recipients of funding from the National Institutes of Health, with $392 million awarded in the 2013 fiscal year.
The University of Pennsylvania Health System's patient care facilities include: The Hospital of the University of Pennsylvania -- recognized as one of the nation's top "Honor Roll" hospitals by U.S. News & World Report; Penn Presbyterian Medical Center; Chester County Hospital; Penn Wissahickon Hospice; and Pennsylvania Hospital -- the nation's first hospital, founded in 1751. Additional affiliated inpatient care facilities and services throughout the Philadelphia region include Chestnut Hill Hospital and Good Shepherd Penn Partners, a partnership between Good Shepherd Rehabilitation Network and Penn Medicine.
Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2013, Penn Medicine provided $814 million to benefit our community.